Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine
- 1 January 1992
- Vol. 10 (8) , 547-550
- https://doi.org/10.1016/0264-410x(92)90355-n
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its SequenceScience, 1991
- Dual action of anti-sporozoite antibodies in vitro.The Journal of Immunology, 1989
- In‐vitro exoerythrocytic development of Plasmodium cynomolgi bastianellii inhibitory activity of monoclonal antibodies against sporozoites of different P. cynomolgi strains and of P. knowlesiParasite Immunology, 1989
- The circumsporozoite gene of the plasmodium cynomolgi complexCell, 1987
- Circumsporozoite proteins of malaria parasitesCell, 1985
- Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum MalariaScience, 1985
- Induction with a synthetic peptide of antibodies to HLA class I C-terminal intracytoplasmic regionMolecular Immunology, 1984
- The protective antigen of malarial sporozoites (Plasmodium berghei) is a differentiation antigen.The Journal of Immunology, 1981
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.The Journal of Experimental Medicine, 1980
- Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium bergheiNature, 1967